IBSA USA
Heather Bertha is an accomplished marketing professional with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as Marketing Director at IBSA USA since July 2024, Heather previously held the position of Lead, Digital Strategy NA at Amylyx Pharmaceuticals. With a background that includes key roles at QuidelOrtho, Caldwell University, Measurement Mojo, ThinkPoint Marketing LLC, Archimedes Pharma, Aton Pharma, and Enzon Pharmaceuticals, Heather has excelled in digital marketing strategy, campaign execution, and team leadership, particularly in driving customer engagement and demand generation. Educational qualifications include a Bachelor of Science in Accounting from Penn State University and two MBAs from Saint Joseph's University.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.